Touareg Group Expands Global Presence with Establishment of U.S. Technology Subsidiary
NEW YORK, Oct. 13, 2025 /PRNewswire/ -- Touareg Group, an international leader…
Rocket Doctor Signs Contracts with Major U.S. Insurers, Expanding Access to Over 7 Million Patients Across California and New York
October 08, 2025 08:00 ET Â | Source: Rocket Doctor AI Inc. Rocket…
GLG Publishes Report on Impact of U.S. Tariffs on Asia-Pacific Businesses
Survey of 300+ senior APAC business leaders shows half have shifted market…
U.S. Critical Materials and GreenMet Join Forces in Strategic Alliance for Gallium and Critical Mineral Independence
WASHINGTON and SALT LAKE CITY, Sept. 26, 2025 /PRNewswire/ -- US Critical…
Pictor Secures Funding to Accelerate U.S. Expansion through Partner-Informed Proteomics Solutions
CARLSBAD, Calif., Sept. 23, 2025 /PRNewswire/ --Â Pictor Holdings Inc., a global leader…
NYSE Content Advisory: Pre-Market update + Mike Waltz, U.S. Ambassador to UN, rings Opening Bell
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- The New York Stock Exchange…
Beehive Industries Hits Rapid Milestones with Frenzy Engine Testing Under U.S. Air Force Contract
Company completes comprehensive tests on four engines in just six months, proving…
Glac Biotech Secures U.S. Food and Drug Administration GRAS Approval for Probiotic Strain CP-9
TAIPEI, Sept. 15, 2025 /PRNewswire/ -- Glac Biotech, a Taiwan-based developer of…
TARIFF FEARS DRIVE U.S. STOCKPILING IN AUGUST, WHILE MANUFACTURING WEAKENS IN EUROPE AND ASIA: GEP SUPPLY CHAIN VOLATILITY INDEX
North America's supply chains get busier, with sharp stockpiling of components to…
![U.S. FDA Approves Expanded Indication for VONVENDI [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease](https://i3.wp.com/mms.businesswire.com/media/20250905840795/en/1247790/22/Takeda_Red_Logo_2021.jpg?w=420&resize=420,280&ssl=1 "U.S. FDA Approves Expanded Indication for VONVENDI [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease"){kind=logo}
U.S. FDA Approves Expanded Indication for VONVENDI [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease
− Approval Expands Use of VONVENDI to Include Routine Prophylaxis to Reduce…